Hydroxybenzohydroxamic acids, benzamides and esters as ribonucle

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2605005H, 424315, 424317, 424324, 560 72, 564177, 564179, A61K 31235, A61K 31185, C07C10326, C07C 6978

Patent

active

043943896

ABSTRACT:
Di and trihydroxybenzohydroxamic acids, amides, alkyl substituted amides and phenyl esters, ribonucleotide reductase inhibitors.

REFERENCES:
patent: 2849480 (1958-08-01), Krenchmann
patent: 4263322 (1981-04-01), van't Riet et al.
Child et al., CA 76:43275e (1972).
Gale, Proc. Soc. Exptl. Biol. Med., 122 1236 (1966).
Gale & Hynes, J. Med. Chem., 11, 191 (1968).
Howle & Gale, Proc. Soc. Exptl. Biol. Med., 131, 697 (1969).
Gale, Hynes & Smith, J. Med. Chem., 14, 571 (1970).
Gale & Carnes, Clin. Pharm. 20, 2677 (1971).
CA 85, 94115 (1976).
CA 81, 120190f (1974).
CA 74, 112752f (1971).
Elford et al., Can. Res., 39, 844 (1979).
van't Riet et al., J. Med. Chem., 22, 589 (1979).
Elford et al., AACR Abstracts 601 Mar. 1979.
Elford AACR Abstracts 707 Mar. 1977.
Elford et al., AACR Abstracts 250 Mar. 1978.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Hydroxybenzohydroxamic acids, benzamides and esters as ribonucle does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hydroxybenzohydroxamic acids, benzamides and esters as ribonucle, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxybenzohydroxamic acids, benzamides and esters as ribonucle will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-751452

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.